Published January 6, 2020 | Version Author version
Journal article Open

cd2sbgnml: bidirectional conversion between CellDesigner and SBGN formats

  • 1. European Institute for Systems Biology and Medicine
  • 2. Institut Curie
  • 3. Luxembourg Centre for Systems Biomedicine
  • 4. Bilkent University

Description

Motivation: CellDesigner is a well-established biological map editor used in many large-scale scientific efforts (Funahashi et al., 2007). However, the interoperability between the Systems Biology Graphical Notation (SBGN) Markup Language (SBGN-ML) and the CellDesigner file format remains a challenge due to the proprietary extensions used in CellDesigner files.

Results: We introduce a library named cd2sbgnml and an associated web service for bidirectional conversion between CellDesigner’s proprietary Systems Biology Markup Language (SBML) extension and SBGN-ML formats. We discuss the functionality of the cd2sbgnml converter, which was successfully used for the translation of comprehensive large-scale diagrams such as the RECON Human Metabolic network (Noronha et al., 2019) and the complete Atlas of Cancer Signalling Network (Kuperstein et al., 2015), from the CellDesigner file format into SBGN-ML.

Availability: The cd2sbgnml conversion library and the web service were developed in  Java, and distributed under the GNU Lesser General Public License v3.0. The sources along with a set of examples are available on GitHub (https://github.com/sbgn/cd2sbgnml and https://github.com/sbgn/cd2sbgnml-webservice, respectively).

Notes

The paper is supported by Scientific and Technological Research Council of Turkey [111E036 to U.D.]

Files

Balaur2020Bioinformatics_AuthorVersion.pdf

Files (510.4 kB)

Name Size Download all
md5:7bc388c8d13b8caaa7a853b0a86d43fc
510.4 kB Preview Download

Additional details

Funding

iPC – individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology 826121
European Commission
PrECISE – PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION 668858
European Commission